Implications of protein- and Peptide-based nanoparticles as potential vehicles for anticancer drugs.

Abstract

Protein-based nanocarriers have gained considerable attention as colloidal carrier systems for the delivery of anticancer drugs. Protein nanocarriers possess various advantages including their low cytotoxicity, abundant renewable sources, high drug-binding capacity, and significant uptake into the targeted tumor cells. Moreover, the unique protein structure… (More)
DOI: 10.1016/bs.apcsb.2014.12.002

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics